Selling, general & administrative increased 25.4%
Selling, general & administrative changed +25.4% from the comparable as-filed period.
$38.4M→$48.1M3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Selling, general & administrative changed +25.4% from the comparable as-filed period.
Research & development changed +17.2% from the comparable as-filed period.
Stock-based compensation changed +21.9% from the comparable as-filed period.
SBC / revenue changed -70 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.